Salvianolate has been widely used for the treatment of cerebrovascular diseases. However, the detailed molecular mechanism of how it alleviates cerebral ischaemia-reperfusion injury is not well understood. In the present study, we investigated the neuroprotective effects of salvianolate in acute cerebral infarction using the PC12 cell oxygen-glucose deprivation (OGD) model in vitro and the rat transient middle cerebral artery occlusion (MCAO) model in vivo. The results showed that the salvianolate significantly reduced the level of reactive oxygen species and inhibited the Caspase-3 signalling pathway in vitro; at the same time, in vivo experiments showed that salvianolate obviously reduced the infarct area (12.9%) and repaired cognitive function compared with the model group (28.28%). In conclusion, our data demonstrated that the salvianolate effectively alleviated cerebral ischaemia-reperfusion injury via suppressing the Caspase-3 signalling pathway.
Neuroprotective effect of salvianolate on cerebral ischaemia-reperfusion injury in rats by inhibiting the Caspase-3 signal pathway.
Pengwei Luan,Jiazhen Xu,Xinyue Ding,Qianfei Cui,Lixian Jiang,Yulan Xu,Yuying Zhu,Ruixiang Li,Guo-qiang Lin,Ping Tian,Jiange Zhang
Published 2020 in European Journal of Pharmacology
ABSTRACT
PUBLICATION RECORD
- Publication year
2020
- Venue
European Journal of Pharmacology
- Publication date
2020-01-21
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-44 of 44 references · Page 1 of 1
CITED BY
Showing 1-18 of 18 citing papers · Page 1 of 1